MY162054A - Inhibitor of attachment of periodontal disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications - Google Patents

Inhibitor of attachment of periodontal disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications

Info

Publication number
MY162054A
MY162054A MYPI2013001753A MYPI2013001753A MY162054A MY 162054 A MY162054 A MY 162054A MY PI2013001753 A MYPI2013001753 A MY PI2013001753A MY PI2013001753 A MYPI2013001753 A MY PI2013001753A MY 162054 A MY162054 A MY 162054A
Authority
MY
Malaysia
Prior art keywords
inhibitor
oral
teeth
attachment
periodontal disease
Prior art date
Application number
MYPI2013001753A
Inventor
Masato Maruyama
Seiji Morishima
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY162054A publication Critical patent/MY162054A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734Alginic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROVIDED ARE: AN INHIBITOR OF THE ATTACHMENT OF A PERIODONTAL DISEASE-INDUCING BACTERIUM ONTO THE SURFACES OF TEETH, WHICH HAS AN EXCELLENT EFFECT OF INHIBITING THE ATTACHMENT OF THE PERIODONTAL DISEASE-INDUCING BACTERIUM ONTO THE SURFACES OF TEETH; AN ORAL BIOFILM FORMATION INHIBITOR WHICH HAS AN EXCELLENT EFFECT OF INHIBITING THE ATTACHMENT OF THE PERIODONTAL DISEASE-INDUCING BACTERIUM ONTO THE SURFACES OF TEETH AND CAN EXHIBIT A HIGH BIOFILM-STERILIZING EFFECT; AND A COMPOSITION FOR ORAL APPLICATIONS. AN INHIBITOR OF THE ATTACHMENT OF A PERIODONTAL DISEASE-INDUCING BACTERIUM ONTO THE SURFACES OF TEETH, WHICH COMPRISES (A) ALGINIC ACID PROPYLENE GLYCOL ESTER; AN ORAL BIOFILM FORMATION INHIBITOR WHICH COMPRISES (A) ALGINIC ACID PROPYLENE GLYCOL ESTER AND (B) ISOPROPYL METHYL PHENOL; AND A COMPOSITION FOR ORAL APPLICATIONS, WHICH IS CHARACTERIZED BY COMPRISING (A) ALGINIC ACID PROPYLENE GLYCOL ESTER AND (B) ISOPROPYL METHYL PHENOL.
MYPI2013001753A 2010-11-30 2011-10-14 Inhibitor of attachment of periodontal disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications MY162054A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010266002 2010-11-30

Publications (1)

Publication Number Publication Date
MY162054A true MY162054A (en) 2017-05-31

Family

ID=46171553

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013001753A MY162054A (en) 2010-11-30 2011-10-14 Inhibitor of attachment of periodontal disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications

Country Status (5)

Country Link
JP (1) JP5729391B2 (en)
KR (1) KR101820192B1 (en)
CN (1) CN103237538B (en)
MY (1) MY162054A (en)
WO (1) WO2012073601A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102191271B1 (en) * 2013-03-27 2020-12-15 라이온 가부시키가이샤 Composition for oral cavity
JP2017119639A (en) * 2015-12-28 2017-07-06 花王株式会社 TRPV4 activator
KR102627187B1 (en) 2016-05-26 2024-01-22 킴벌리-클라크 월드와이드, 인크. Anti-adhesion compositions and methods for inhibiting adhesion of microorganisms to surfaces
KR20200093514A (en) * 2017-11-30 2020-08-05 라이온 가부시키가이샤 Oral biofilm formation inhibitor and oral composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2806031B2 (en) * 1990-10-01 1998-09-30 ライオン株式会社 Oral composition
JPH1171251A (en) * 1997-08-29 1999-03-16 Lion Corp Composition for oral cavity
JPH1171250A (en) * 1997-08-29 1999-03-16 Lion Corp Composition for oral cavity
JP4763441B2 (en) * 2004-12-10 2011-08-31 花王株式会社 Plaque formation inhibitor and oral composition and food containing the same
JP2006176479A (en) * 2004-12-24 2006-07-06 Lion Corp Toothpaste composition
US20070140992A1 (en) * 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
JP5041135B2 (en) * 2006-12-26 2012-10-03 ライオン株式会社 Oral composition and oral biofilm formation inhibitor
JP2009149535A (en) * 2007-12-19 2009-07-09 Lion Corp Oral composition
JP5552725B2 (en) * 2007-12-27 2014-07-16 ライオン株式会社 Oral composition and oral biofilm disinfectant

Also Published As

Publication number Publication date
CN103237538B (en) 2016-01-20
KR101820192B1 (en) 2018-01-18
CN103237538A (en) 2013-08-07
WO2012073601A1 (en) 2012-06-07
JP5729391B2 (en) 2015-06-03
JPWO2012073601A1 (en) 2014-05-19
KR20140000267A (en) 2014-01-02

Similar Documents

Publication Publication Date Title
MY156518A (en) Borinic compositions
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
WO2012065019A3 (en) Combination comprising pyridopyrimidinone inhibitors of pi3k alpha
MX340950B (en) Stable oral care compositions.
TN2012000575A1 (en) Compositions and methods for modulating the wnt signaling pathway
MX2012003982A (en) Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions.
RS54623B1 (en) Polyethylene glycol based prodrug of adrenomedullin and use thereof
MX2013004162A (en) Pharmaceutical compositions containing a dgat1 inhibitor.
PH12015502154A1 (en) Composition for oral cavity
CA2934501C (en) Oral care compositions and methods
PH12016501034A1 (en) Oral care compositions and methods
CL2012003487A1 (en) Oral pharmaceutical composition comprising a compound derived from quinqzoline and alginic acid or sio2 as an acidic additive.
IL195572A0 (en) Controlled release formulations
AU2010356056A8 (en) Phosphoric acid ester compound of hydroxy acid substituted phenyl ester, synthesis method and medical use thereof
EA201300688A1 (en) NEW FORM OF INTRODUCTION ENECHALINASE INHIBITOR
MY162054A (en) Inhibitor of attachment of periodontal disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications
MX354241B (en) Oral care compositions and methods.
WO2011011420A3 (en) 3, 4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor
RS53546B1 (en) Composition for inhibiting inflammation comprising hyaluronic acid and a hmg-coa reductase inhibitor
MX358871B (en) Oral care compositions and methods.
MX2012002580A (en) Novel antibacterial hydroxyphenyl compound.
MX2016008211A (en) Oral care compositions and methods.
EP2568810A4 (en) Darunavir compositions
MX354872B (en) Oral care compositions and methods.
EP2538796A4 (en) Gum bases having reduced polarity and chewing gums based thereupon